Skip to main content

Ocrevus Zunovo Prices, Coupons, Copay Cards & Patient Assistance

Ocrevus Zunovo (hyaluronidase/ocrelizumab) is a member of the CD20 monoclonal antibodies drug class and is commonly used for Multiple Sclerosis.

The cost for Ocrevus Zunovo (ocsq 23,000 units-920 mg /23 mL) subcutaneous solution is around $44,079 for a supply of 23 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Ocrevus Zunovo prices

Subcutaneous Solution

ocsq 23,000 units-920 mg /23 mL

Ocrevus Zunovo subcutaneous solution

 from $44,079.27

for 23 milliliters
Quantity Per unit Price
23 milliliters $1,916.49 $44,079.27

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Ocrevus Zunovo Coupons, Copay Cards and Rebates

Ocrevus Zunovo offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

No manufacturer promotions could be found for this medication.

Patient Assistance & Copay Programs for Ocrevus Zunovo

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) Injection for Subcutaneous use

More information please phone: 866-316-7263 Visit Website

Provider: Genentech Access Solutions: Ocrevus

Eligibility requirements:
  1. Determined case by case
  2. Based on FPL
  3. Medically appropriate condition/diagnosis
  4. Must be treated by US licensed healthcare provider
  5. Eligibility determined on a case-by-case basis. Contact program for details.
Applicable drugs:
  • Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) Injection for Subcutaneous use

More information please phone: 800-888-2882   or 866-422-2377   Visit Website

Provider: Genentech Patient Foundation

Eligibility requirements:
  1. Uninsured or Underinsured with no prescription coverage for needed medication
  2. Based on FPL
  3. Medically appropriate condition/diagnosis
  4. Must be treated by US licensed healthcare provider
  5. The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
Applicable drugs:
  • Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) Injection for Subcutaneous use

More information please phone: 888-941-3331   or 866-422-2377   Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.